Screening of the Frailty Degree in the Emergency Department Short Stay Unit
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04812834 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 24, 2021
Last Update Posted : April 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Frail Elderly Syndrome |
Demographic change has led to a change in the profile and age of hospitalized patients, an increase in age and in patients with multiple chronic diseases and more complex health needs is observed.
Frailty is known to impact patient health outcomes with medical and surgical procedures. Thus, frailty is correlated with a greater presence of delirium, longer stays, a greater requirement for complementary examinations, a greater presence of mortality and other post-surgical complications, more dependence, more risks derived from hospitalization, and a greater need for convalescence after discharge.
| Study Type : | Observational [Patient Registry] |
| Actual Enrollment : | 300 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 12 Months |
| Official Title: | Systematic Detection and Screening of the Frailty Degree in Patients Admitted to the Emergency Department Short Stay Unit |
| Actual Study Start Date : | February 24, 2021 |
| Estimated Primary Completion Date : | February 24, 2022 |
| Estimated Study Completion Date : | February 24, 2023 |
- To know the degree of frailty with the frail VIG index in patients admitted to the short-stay unit [ Time Frame: 12 months ]The Frail Vig index ("VIG" is the spanish/catalan abbreviation for Comprehensive Geriatric Assessment) is a new, more concise Frailty index for rapid geriatric assessment, which contains 22 simple questions that assess 25 different deficits. The Frail VIG index score assesses the degree of frailty as a continuous variable. The value of the Frail VIG index is between 0 (absence of frailty) and 0.7 (severe frailty)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years and older (Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients over 65 years of age admitted to the Short Stay Unit
Exclusion Criteria:
- Patients under 65 years of age admitted to the Short Stay Unit
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04812834
| Spain | |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Barcelona, Spain, 08025 | |
| Principal Investigator: | Josep JA Montiel Dacosta, PhDs | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Responsible Party: | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| ClinicalTrials.gov Identifier: | NCT04812834 |
| Other Study ID Numbers: |
IIBSP-FRA-2020-74 |
| First Posted: | March 24, 2021 Key Record Dates |
| Last Update Posted: | April 1, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
elderly frailty short stay unit |
|
Emergencies Frailty Disease Attributes Pathologic Processes |